Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 282

The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.

Tau PET imaging: present and future directions

Open access
Saint-Aubert, Laure, Lemoine, Laetitia, Chiotis, Konstantinos, Leuzy, Antoine, Rodriguez-Vieitez, Elena, Nordberg, Agneta·2017·Molecular Neurodegeneration

Abstract

Abnormal aggregation of tau in the brain is a major contributing factor in various neurodegenerative diseases. The role of tau phosphorylation in the pathophysiology of tauopathies remains unclear. Consequently, it is important to be able to accurately and specifically target tau deposits in vivo in the brains of patients. The advances of molecular imaging in the recent years have now led to the recent development of promising tau-specific tracers for positron emission tomography (PET), such as THK5317, THK5351, AV-1451, and PBB3. These tracers are now available for clinical assessment in patients with various tauopathies, including Alzheimer's disease, as well as in healthy subjects. Exploring the patterns of tau deposition in vivo for different pathologies will allow discrimination between neurodegenerative diseases, including different tauopathies, and monitoring of disease progression. The variety and complexity of the different types of tau deposits in the different diseases, however, has resulted in quite a challenge for the development of tau PET tracers. Extensive work remains in order to fully characterize the binding properties of the tau PET tracers, and to assess their usefulness as an early biomarker of the underlying pathology. In this review, we summarize recent findings on the most promising tau PET tracers to date, discuss what has been learnt from these findings, and offer some suggestions for the next steps that need to be achieved in a near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-017-0162-3

Cites

127 of 127 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 127 references

Research works printed but not linked: 2

  1. Human Amyloid Imaging Conference Book of Abstract. Human Amyloid Imaging: 11–13 January 2017. Miami: World Events Forum, Inc.; 2017.
  2. Alzheimer’s Association International Conference Book of Abstract. In: Alzheimer’s Association International Conference (AAIC): 18–23 July 2015; Washington; Elsevier; 2015. p. 283.

Cited by

See all 282

Metadata

Authors
Saint-Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez-Vieitez, E., & Nordberg, A.
Venue
Molecular Neurodegeneration
Published
2017-02-20
Volume
12
Issue
1
Pages
19-19
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2590870875
Cited by
282
References
127
FWCI
26.27
Type
journal article
Language
en
Open access
gold
Funders
  • Wenner-Gren Foundations
  • Swedish Foundation for Strategic Research (SSF)
  • Regional Agreement on Medical Training and Clinical Research (ALF) for Stockholm County Council
  • Foundation for Old Servants
  • Swedish Brain Foundation
  • Alzheimerfonden
  • INMiND
  • Vetenskapsrådet (05817)
  • KTH-SLL research grant ((K1764-2013)”.)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau PET imaging: present and future directions. https://app.cochat.ai/papers/10.1186/s13024-017-0162-3
The paper
Saint-Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez-Vieitez, E., & Nordberg, A. (2017). Tau PET imaging: present and future directions. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-017-0162-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.